.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Royal Cannabis (MO) is stocked at 55 licensed dispensaries across Missouri, with the deepest coverage in St. Louis, Kansas City, Springfield, Cape Girardeau, and Columbia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Royal Cannabis (MO) concentrated 90.64% of sales in Flower with category sales up 241.32% year over year but edging down 0.63% month over month, while Vapor Pens held 3.64% share with sales down 60.98% YoY and up 5.60% MoM. Pre-Roll accounted for 3.05% share with a 59.31% YoY decline and a 31.34% MoM drop, whereas Concentrates captured 2.67% share with 21.47% YoY growth and a 51.43% MoM spike. The brand’s average price rose 23.11% YoY to $31.80 even as Flower averaged $33.29 and Vapor Pens averaged $36.64, indicating a price-led tilt within its dominant segment. The pattern implies a high-concentration Flower strategy in Missouri that lifted overall sales 119.43% YoY but left exposure to MoM volatility in non-Flower lines.
With Flower at 90.64% share and ranked 31 in Missouri Flower, the brand trades depth for breadth, leveraging a 241.32% YoY surge in its core while accepting a 0.63% MoM dip to maintain volume at higher price points. Simultaneously, a 51.43% MoM rise in Concentrates against a 31.34% MoM decline in Pre-Roll signals a pivot toward higher-value inhalables, as Vapor Pens’ 5.60% MoM uptick partially offsets its 60.98% YoY contraction. The pattern implies near-term share defense through premiumized Flower and selective expansion in Concentrates to stabilize rank and reduce reliance on a single category.
Competitive Landscape
Royal Cannabis (MO) is currently ranked #31 in Missouri Flower in September 2026, improving 21 positions from #52 year over year, and rising 9 spots from #40 in June 2026; this month also marks its peak rank at #31. In directional contrast, Flora Farms held steady at #1 year over year while Amaze Cannabis climbed from #6 to #2 as its sales grew approximately 19.8%, whereas Sinse Cannabis stayed at #3 with sales down about 11.1%. The progression from #52 to #31, coupled with a quarter-on-quarter move from #40 to #31, implies Royal Cannabis (MO) is transitioning from lower-tier visibility toward mid-pack relevance, but headroom remains given competitors’ hold on ranks #1–#3.
Notable Products
Cheetah Piss (3.5g) posted the steepest move in September 2026 with a -64.5% month-over-month drop and sits at rank 7, while GMO Bomb (3.5g) also contracted by -24.7% at rank 3. Cap Junky (3.5g) held rank 1 with a modest -1.3% decline, and Banana Cream Jealousy (3.5g) was the lone climber among named eighths at +11.8% in rank 5. Four of the top ten are Bulk Flower SKUs clustered between ranks 4 and 10, and Moonshot (Bulk) slipped -14.7% to rank 8, signaling that unit-weighted bulk is anchoring share even as some core eighths retrench. The pattern implies Royal Cannabis (MO) is leaning into a bulk-heavy mix for September 2026 while rationalizing underperforming eighths, prioritizing volume tiers over breadth in premium 3.5g SKUs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
